I might be wrong and im sure someone will correct me but MSB has 1.16 billion shares on issue on one drug to serve only 10,000 people per year and compare it to PIQ with numerous Endo Markers etc and only 139 million shares on issue is to my mind a far better bet in my book.
Both companies are at the same starting gates to the sales process and MSB is valued by the market at $3.3 billion and PIQ only $90 million. What am I missing in my equation?
who can compare better?
Ann: December 2024 Quarterly Activities Report and Appendix 4C, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $58.86M | |||
| Open | High | Low | Value | Volume |
| 36.5¢ | 37.0¢ | 35.5¢ | $89.35K | 246.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 99321 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 7502 | 1 |
View Market Depth
| Last trade - 15.58pm 16/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |